Literature DB >> 20363301

The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.

Waseem Kaialy1, Gary P Martin, Martyn D Ticehurst, Mohammed N Momin, Ali Nokhodchi.   

Abstract

The aim of the present study was to investigate the effect of crystallising mannitol from different binary mixtures of acetone/water on the resultant physical properties and to determine the effects of any changes on in vitro aerosolisation performance, when the different mannitol crystals were used as a carrier in dry powder inhaler formulations containing salbutamol sulphate. Mannitol particles were crystallised under controlled conditions by dissolving the sugar in water and precipitating the sugar using binary mixtures of acetone/water in different percentages as anti-solvent media. For comparison purposes the physical properties and deposition behaviour of commercially available mannitol were also studied. SEM showed that all crystallised mannitol particles were more elongated than the commercial mannitol. Solid state studies revealed that commercial mannitol and mannitol crystallised using acetone in the presence of 10-25% v/v water as anti-solvent was beta-polymorphic form whereas mannitol crystallised in the presence of a small amount of water (0-7.5%) was the alpha-form. All the crystallised mannitol samples showed poor flowability. Nevertheless, the powdered crystallised mannitol and commercial samples were blended with salbutamol in the ratio 67.5:1. The aerosolisation performance of the formulations containing the engineered mannitol (evaluated using Multi Stage Liquid Impinger) was considerably better than that of the commercial mannitol formulation (the fine particle fraction was increased from 15.42% to 33.07-43.99%, for the formulations containing crystallised mannitol). Generally, carriers having a high tapped density and high fraction of fine carrier particles produced a high FPF. The improvement in the DPI performance could be attributed to the presence of elongated carrier particles with smooth surfaces since these are believed to have less adhesive forces between carrier and the drug resulting in easier detachment of the drug during the inhalation. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363301     DOI: 10.1016/j.ijpharm.2010.03.057

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

3.  The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Authors:  Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

4.  Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.

Authors:  Waseem Kaialy; Gary P Martin; Martyn D Ticehurst; Paul Royall; Mohammad A Mohammad; John Murphy; Ali Nokhodchi
Journal:  AAPS J       Date:  2010-11-06       Impact factor: 4.009

5.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

6.  The effect of solvent treatment on the performance of various carriers in dry powder inhalations containing salbutamol sulphate.

Authors:  Mohammad Reza Siahai Shadbad; Leonie Millen; Mn Momin; Ali Nokhodchi
Journal:  Iran J Basic Med Sci       Date:  2013-07       Impact factor: 2.699

7.  Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation.

Authors:  Tingting Peng; Xuejuan Zhang; Ying Huang; Ziyu Zhao; Qiuying Liao; Jing Xu; Zhengwei Huang; Jiwen Zhang; Chuan-Yu Wu; Xin Pan; Chuanbin Wu
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 8.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

9.  Preparation of slab-shaped lactose carrier particles for dry powder inhalers by air jet milling.

Authors:  Xiang Kou; Lai Wah Chan; Changquan Calvin Sun; Paul Wan Sia Heng
Journal:  Asian J Pharm Sci       Date:  2016-09-21       Impact factor: 6.598

10.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.